|
Re: Hepa Mystery???
|
3
|
Resverlogix Corp.
|
Jul 10, 2016 04:08PM
|
|
Re: State of Emergency
|
3
|
Resverlogix Corp.
|
Jul 22, 2016 04:46PM
|
|
Re: ... IT'S ABOUT TIME...!!!!!!!!!!!
|
3
|
Resverlogix Corp.
|
Nov 23, 2017 10:10AM
|
|
Re: It's Time For Zenith To Disclose
|
3
|
Zenith Epigenetics
|
Jan 31, 2017 09:18PM
|
|
Re: Hedge Knight Capital Discussion
|
3
|
Resverlogix Corp.
|
May 28, 2019 11:51AM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
3
|
Resverlogix Corp.
|
Dec 02, 2019 02:42PM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
3
|
Resverlogix Corp.
|
Mar 21, 2019 09:46AM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
3
|
Resverlogix Corp.
|
Sep 09, 2017 06:33PM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Aug 18, 2019 02:26PM
|
|
Re: i quote what someboday else posts back to me & I my post gets banned, come on..
|
3
|
Resverlogix Corp.
|
Sep 18, 2015 10:32AM
|
|
Resverlogix Receives Approval Pathway from the FDA as to the Inclusion of USA Patients in the Phase 3 BETonMACE Trial
|
3
|
Resverlogix Corp.
|
Jul 25, 2017 09:48AM
|
|
Epigenetic drugs, cardiometabolic disease and atherosclerosis
|
3
|
Resverlogix Corp.
|
Oct 16, 2018 04:45PM
|
|
Re: Name Confusion
|
3
|
Zenith Epigenetics
|
Jul 29, 2020 11:36AM
|
|
RVX ANNOUNCES LEAD DRUG APABETALONE PUBLICATION AND BIO 2016 PRESENTATION
|
3
|
Resverlogix Corp.
|
Jun 02, 2016 08:33AM
|
|
Resverlogix to press on with trial of cardiovascular drug after safety review
|
3
|
Resverlogix Corp.
|
Aug 15, 2016 11:07AM
|
|
Re: AZ- Another one bites the dust!
|
3
|
Resverlogix Corp.
|
Sep 09, 2019 04:18PM
|
|
Re: Streetwise reports reporting on Dr. Kideckel's report for Beacon....
|
3
|
Resverlogix Corp.
|
Dec 06, 2017 05:17PM
|
|
Re: New Share Price Contest
|
3
|
Resverlogix Corp.
|
Oct 11, 2019 12:26PM
|
|
Re: If BP buys Apabetalone,...
|
3
|
Resverlogix Corp.
|
Nov 06, 2019 09:38PM
|
|
Re: New MD&A posted
|
3
|
Resverlogix Corp.
|
Dec 18, 2019 08:29PM
|
